Five sector pros discuss adapting to patient-centricity and how pinpointing patient needs leads to success.
In general, physicians believe that information provided by pharma companies is difficult to find and lacking in science.
Docs spend little time telling patients about cancer costs; Shire to file hereditary angioedema drug with the FDA by 2018; Philips CEO on access obstacles
FDA approves Merck/Lilly combo for lung cancer; new PhRMA requirements result in expulsion of 22 members; Pfizer to pay Sangamo $7 million for gene therapy programs
How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?
Dr. Ashish Atreja is the director of the Sinai AppLab at the Icahn School of Medicine.
Dr. Susan Kornstein is co-founder and executive director of the Virginia Commonwealth University Institute for Women's Health.
Healthcare is one industry that hangs in this delicate balance, in large part due to the fact that it necessitates a blend of science and empathy.
Novartis ordered to turn over files about 80,000 speaking events; drugmakers set lower-than-expected prices at launch; funding goes to R&D of antibiotics
We had SERMO, a social network for physicians, ask about 1,700 physicians what they have to say about the impact of DTC on patient care and choices. Note: It's not pretty.
Healthcare is sometimes about life or death, but is almost always about quality of life, says the EVP of health system products and strategy.
Organizations are focusing on better ways to verify HCPs' digital identities.
He instead decided to find a way to make a physician's job easier by creating a clinical messaging platform.
There are also issues surrounding privacy and legitimacy. According to one expert's research, very few physicians use social media for professional purposes.
Pharmaceutical companies often blur the lines between a drug's risks and benefits in ads, and that frustrates physicians.
About 30% of patients are more likely to fill a prescription after being exposed to healthcare ads at the point of care, according to Kantar Media.
Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March
The presumption is Dr. A saw ad B, clicked on it, went to the site and within C time, prescribed product D.
Physicians do not like EHRs. That much is clear. But the vast majority have to use electronic record systems on a daily basis. What can pharma do to better give doctors what they want?
A recent CME course using Facebook Live generated 34,000 views and 600 comments.
Allergan to settle allegations relating to speakers bureaus; Mylan launches generic version of the EpiPen; 20 states sue six drugmakers accused of price-fixing
Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.
How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy
More barriers separate doctors and patients than ever before, from rising costs and time constraints to electronic health records and smartphones.
As part of the acquisition, 160 AccentHealth employees will join ContextMedia, which has a staff of about 500 people.
Drugmakers can do a better job of organizing dosing information, safety information, and clinical data on their brand websites, a new survey found.
The AMA votes in favor of value-based drug pricing; Amgen says insurers are balking at PCSK9 inhibitor prices; docs aren't focused on prices when prescribing
Insurers and pharmacy benefit managers already have a sophisticated understanding of clinical data, the industry argued.
How pharma distributes information to doctors is changing as rapidly as how doctors prefer to receive and process such information
It's becoming less and less likely that an in-person physician/sales rep interaction will take place at the healthcare provider's office.
- Study: One-third of docs trust pharma content on HCP sites
- Five things for pharma marketers to know: Wednesday, May 17, 2017
- Five things for pharma marketers to know: Monday, May 22, 2017
- Five things for pharma marketers to know: Tuesday, May 23, 2017
- Five things for pharma marketers to know: Friday, May 19, 2017
Live at MM&M Transforming Healthcare
In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.
One executive referred to AI as a "black box" and as the "Tower of Babel."
Execs stressed the importance of collaboration, consumer-mindedness.
The artificial pancreas can provide value to the health system.
MM&M honors 40 upstarts and veteran innovation gurus.
For the first time MM&M honors a group of 10 agency execs.